United Therapeutics CEO Martine Rothblatt reports UTHR common share sale worth $4.97 million - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt reports UTHR common share sale worth $4.97 million
U
UTHR• Martine Rothblatt trust reports option exercise and share sale
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported a trust-held option exercise of 9,500 shares at $135.42 on July 16, 2026.
- The same trust sold 9,500 shares in a series of trades at weighted-average prices of about $527.31 to $537.11.
- The trust-held common stock position ended at 324,443 shares following the transactions.
- The trust-held stock options ended at 331,910 shares following the exercise.
CRCT
•
